Related Experiment Video
Updated: Sep 16, 2025
06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
38.4K
Bone Marrow Farnesoid X Receptor Deficiency Does Not Impact Atherosclerosis Susceptibility in Male Low-Density
Menno Hoekstra1,2, Ruud Out2, Zhaosha Li2
1Division of Systems Pharmacology and Pharmacy (M.H., M.V.E.), Leiden Academic Centre for Drug Research, Leiden University, the Netherlands.
Arteriosclerosis, Thrombosis, and Vascular Biology
|July 10, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
01:26Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
01:30Atherosclerosis I: Introduction
92
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
92